|
GE Healthcare signs agreement with Clarient |
|
Monday, 25 October 2010 |
|
GE Healthcare, a unit of General Electric Company (NYSE: GE), and Clarient, Inc. (Nasdaq: CLRT) announced today that they have entered into a definitive agreement for GE Healthcare to acquire Clarient, a leading player in the fast-growing molecular diagnostics sector. Clarient's technologies, combined with GE Healthcare's strengths in diagnostic imaging, are expected to accelerate the development of new integrated tools for the diagnosis and characterization of cancer. A subsidiary of GE will commence a tender offer for all outstanding common and preferred shares of Clarient at $5.00 per common share and $20.00 per preferred share, in each case payable in cash. Molecular diagnostics provide precise information about a patient's cancer and can help doctors decide on the best treatment. The rapid increase in the incidence of cancer worldwide, together with advances in specific cancer-focused therapies, is driving significant demand for molecular diagnostics. The global demand for cancer-profiling products and services is predicted to grow from $15 billion in 2009 to an estimated $47 billion by 2015*. Since 2005, Clarient's revenues have grown at a 68 percent compounded annual growth rate.
|
|
Scientists discover new cell that may limit inflammation in CNS |
|
Monday, 25 October 2010 |
|
Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) - a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis. The research, led by Barrow's Fu-Dong Shi, MD, PhD, was published in the August 2010 issue of The Journal of Experimental Medicine, and simultaneously highlighted in Nature.
|
|
|
New E-Commerce Internet Site for Spectscopy Cuvettes and Flow Cytometry Cells Launched by NSG Precis |
|
Tuesday, 19 October 2010 |
|
Farmingdale, NY (Vocus) October 19, 2010 - NSG Precision Cells, A leading cuvette manufacturer for spectroscopy cuvettes, custom made quartz optical components, and other fine quartz products, is happy to announce the launch of their new e-commerce website. NSG Precision Cells has turned out to be a single best global leader in excellent quality and pricing for quartz and glass cuvettes for spectroscopy, flow cytometry optics, microfluidic chips, and other extremely exact quartz optical components. Since 2008 NSG has been receiving requests from their customers to add an e-commerce choice to their site.
|
|
|
High-Profile Paper Retracted |
|
Friday, 15 October 2010 |
A rising stem cell star has retracted a recent high-profile paper because of "serious concerns" with the data. A second paper in Blood by the same group is also under review. Whether the retraction is due to a mistake or misconduct remains unclear, but a comparison of the papers done by Nature reporters found two sets of flow cytometry plots that seem to be duplicates. Amy Wagers, a stem cell biologist at the Joslin Diabetes Center and assistant professor at Harvard Medical School, published a retraction with two co-authors on Wednesday (October 13) of a January 2010 Nature paper, cited 13 times, which found that factors in the blood of young mice can rejuvenate blood stem cells in older mice.
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
